Abstract:Objective:To explore the role and mechanism of histone deacetylase 3 (HDAC3) in acute kidney injury induced by renal ischemia-reperfusion (I/R).Methods:From April 2021 to October 2021, experiments were carried out in Renmin Hospital of Wuhan University. Totally, 60 C57BL/6 male mice were used to establish renal I/R injury models, and they were randomly divided into sham operation (Sham) group and (I/R) group, I/R+ dimethylsurfoxide (DMSO) group, I/R+ HDAC3 inhibitor AES-135 low, medium and high dose groups. Hematoxylin and eosin (HE) staining was used to assess renal damage. Blood urea nitrogen (BUN) and creatinine (Cr) were used to quantify renal function levels. Western blotting was used to detect HDAC3 and apoptotic protein expression levels. Hydrogen peroxide (H 2O 2), malondialdehyde (MDA) and superoxide dismutase (SOD) were used to assess the level of oxidative stress. Analysis of variance and Tukey-Kramer test were used for comparison between groups. Results:The protein expression level of HDAC gradually increased with the prolongation of hypoxia, and the protein expression level in 45-min hypoxia group was significantly higher than that in sham group (2.147±0.166 vs. 1.013±0.023, F=173.4, P<0.01). Inhibiting the expression of HDAC3 could significantly improve the pathological characteristics of the kidney during I/R and restore renal function. The levels of BUN and Cr in high-dose inhibitor group were significantly lower than those in I/R group (BUN: 26.54±1.16 vs. 60.43±3.06; Cr: 68.67±6.02 vs. 161.70±4.16, F=161.8, P<0.01). The levels of apoptotic proteins bax and cleaved Caspase-3 in high-dose inhibitor group were significantly lower than those in I/R group (bax: 2.273±0.064 vs. 3.483±0.136; cleaved Caspase-3: 1.347±0.028 vs. 1.827±0.069, F=7.2, P<0.05). The levels of H 2O 2, MDA and SOD related to oxidative stress in high-dose inhibitor group were significantly lower than those in I/R group (H 2O 2: 3.82±0.21 vs. 5.89±0.19; MDA: 1.34±0.11 vs. 2.12±0.09; SOD: 154.56±7.21 vs. 71.33±6.51, F=243.9, P<0.01). Conclusion:HDAC3 was up-regulated in renal I/R injury. Inhibition of HDAC3 could attenuate renal I/R injury by reducing cell apoptosis and oxidative stress.

The critical roles of histone deacetylase 3 in the pathogenesis of solid organ injury

Histone Deacetylase 3 Facilitates TNFα-mediated NF-κB Activation Through Suppressing CTSB Induced RIP1 Degradation and is Required for Host Defense Against Bacterial Infection

HDAC3 in action: Expanding roles in inflammation and inflammatory diseases.

The involvement of HDAC3 in the pathogenesis of lung injury and pulmonary fibrosis

Critical Role of histone deacetylase 3 in the regulation of kidney inflammation and fibrosis

The Role of HDAC3 and Its Inhibitors in Regulation of Oxidative Stress and Chronic Diseases

Classical HDACs in the Regulation of Neuroinflammation.

The role and mechanism of histone deacetylase 3 in acute kidney injury induced by renal ischemia-reperfusion

Histone deacetylase 3 (HDAC3) as an important epigenetic regulator of kidney diseases

Role of HDAC3 in Renal Injury Induced by Myocardial Ischemia-Reperfusion in Diabetic Rats

Integrative function of histone deacetylase 3 in inflammation

Integrative regulation of physiology by histone deacetylase 3

Histone Modification Landscape and the Key Significance of H3K27me3 in Myocardial Ischaemia/reperfusion Injury.

The Role of Histone Deacetylases in Acute Lung Injury—Friend or Foe

Histone Deacetylases in Modulating Cardiac Disease and Their Clinical Translational and Therapeutic Implications

Roles of SIRT3 in Heart Failure: from Bench to Bedside.

HDAC3 Contributes to Ischemic Stroke by Regulating Interferon Pathway

The role of extracellular histone in organ injury

The role of histone deacetylases in inflammatory respiratory diseases: an update

HDAC3 inhibition ameliorates ischemia/reperfusion-induced brain injury by regulating the microglial cGAS-STING pathway

Inhibition of HDAC3 Ameliorates Cerebral Ischemia Reperfusion Injury in Diabetic Mice In Vivo and In Vitro